📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Anupam Rasayan to Acquire Jayhawk Fine Chemicals for ~$150 Million
Anupam Rasayan India Ltd. has signed a definitive agreement to acquire Jayhawk Fine Chemicals Corporation, a U.S. based specialty chemical company, for a purchase consideration of approximately $150 million. The purchase consideration translates to an enterprise value of ~$134 million considering ~$16 million of cash. Jayhawk clocked revenues of ~$78 million and adjusted EBITDA of ~$15 million in CY24, resulting in an EV to EBITDA multiple of ~9x. This acquisition will be financed through a mix of internal accruals, debt and quasi equity and is expected to be EPS accretive for Anupam.
Key Highlights
Acquisition of Jayhawk for ~$150 million.
Jayhawk's revenue in CY24 was ~$78 million.
Jayhawk's adjusted EBITDA in CY24 was ~$15 million.
Enterprise value of the deal is ~$134 million.
Anupam operates via its six manufacturing facilities in Gujarat, India, with an aggregate installed capacity of about 30,000 MT as of March 31, 2025.
💼 Action for Investors
Investors should monitor the progress of the acquisition and its impact on Anupam Rasayan's future earnings. Also, keep an eye on how the company integrates Jayhawk's operations and leverages synergies.
Anupam Rasayan to Acquire US-based Jayhawk Fine Chemicals for $155 Million
Anupam Rasayan has approved the 100% acquisition of Monitchem Kansas S.à r.l and its subsidiaries, including US-based Jayhawk Fine Chemicals, for a total consideration of up to $155 million. Jayhawk is a leading CDMO specializing in complex chemical synthesis for agrochemical and life science sectors, reporting a turnover of $78.3 million in FY24. This strategic move establishes a manufacturing presence in the US and provides immediate access to a high-value American customer base. To support this acquisition, the company is seeking shareholder approval to increase borrowing limits and investment caps.
Key Highlights
Acquisition of 100% control of Monitchem Kansas and Jayhawk Fine Chemicals for up to $155 million
Target entity Jayhawk Fine Chemicals reported a steady turnover of $78.3 million in FY24
Strategic entry into the US market with a manufacturing facility in Galena, Kansas
Board seeking approval to increase borrowing limits and investment caps under Sections 180 and 186
Transaction expected to conclude between January and February 2026
💼 Action for Investors
This is a significant strategic expansion that provides a manufacturing foothold in the US and adds high-margin CDMO capabilities. Investors should monitor the impact of the acquisition on the company's debt levels and the subsequent integration of the US operations.
Anupam Rasayan to Acquire Monitchem Kansas for up to USD 155 million
Anupam Rasayan India Limited (ANURAS) has announced the acquisition of Monitchem Kansas S.à r.l and its subsidiaries for up to USD 155 million. This acquisition includes the purchase of a loan receivable from CABB GmbH. The deal aims to strengthen Anupam Rasayan's manufacturing footprint in the United States and provide access to an established American customer base. Shareholders should note that the company is seeking approval to increase its borrowing limits and potentially dispose of a substantial part of its undertaking.
Key Highlights
Acquisition of Monitchem Kansas S.à r.l and its subsidiaries
Purchase of loan receivable from CABB GmbH pertaining to Kansas HoldCo 1, Inc.
Consideration of up to USD 155 million
Target's FY24-25 Turnover: US$78,306,786
Remote e-voting period: December 11, 2025 to January 09, 2026
💼 Action for Investors
Investors should review the postal ballot notice for details on the proposed increase in borrowing limits and potential asset disposal. Monitor the progress of the Monitchem Kansas acquisition for potential growth opportunities.
Anupam Rasayan to Acquire US-based Jayhawk Fine Chemicals for USD 155 Million
Anupam Rasayan has approved the 100% acquisition of Monitchem Kansas S.à r.l and its subsidiaries, including US-based Jayhawk Fine Chemicals, for a total consideration of up to USD 155 million. The target company is a leading CDMO specializing in complex chemical synthesis for agrochemical and life science sectors, reporting a turnover of USD 78.3 million in FY24-25. This strategic move provides Anupam Rasayan with a manufacturing footprint in the United States and immediate access to a niche American customer base. To facilitate this, the board is seeking shareholder approval to increase borrowing and investment limits via a postal ballot.
Key Highlights
Acquisition of 100% control of Monitchem Kansas and Jayhawk Fine Chemicals for an aggregate consideration of up to USD 155 million.
Target entity Jayhawk Fine Chemicals reported a turnover of USD 78.3 million in FY24-25 and USD 79.5 million in FY23-24.
The transaction includes the purchase of a loan receivable from CABB GmbH pertaining to the target group.
The acquisition is expected to be completed between January and February 2026.
Board seeking special resolutions to increase borrowing limits under Section 180(1)(c) and investment limits under Section 186.
💼 Action for Investors
Investors should view this as a major strategic expansion that provides a direct manufacturing presence in the US and diversifies the revenue base. Monitor the upcoming postal ballot results and the subsequent impact of increased leverage on the company's balance sheet.